Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salman Karim

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
The Cochrane Database of Systematic Reviews|March 14, 2019
Computerised cognitive training for preventing dementia in people with mild cognitive impairmentNicola J Gates, Robin Wm Vernooij, Marcello Di Nisio, et al.
International Journal of Geriatric Psychiatry|March 18, 2011
The symptomatology of Alzheimer's disease: a cross-cultural studySalman Karim, Hassan M Minhas, Sharmi Bhattacharya, et al.
The Cochrane Database of Systematic Reviews|March 14, 2019
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlifeNicola J Gates, Anne Ws Rutjes, Marcello Di Nisio, et al.
The Cochrane Database of Systematic Reviews|March 14, 2019
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in late lifeNicola J Gates, Anne Ws Rutjes, Marcello Di Nisio, et al.
The Cochrane Database of Systematic Reviews|February 28, 2020
Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late lifeNicola J Gates, Anne Ws Rutjes, Marcello Di Nisio, et al.
BMJ Open|April 9, 2025
Prevalence of dementia and mild cognitive impairment among the older prisoner population in England and Wales: a cross-sectional studyKatrina Forsyth, Baber Malik, Roger Webb, et al.
BMC Medical Genomics|July 18, 2024
Towards genomic medicine: a tailored next-generation sequencing panel for hydroxyurea pharmacogenomics in TanzaniaSiana Nkya, Collin Nzunda, Emmanuel Saukiwa, et al.
The Pharmacogenomics Journal|April 23, 2025
Exploring pharmacogenetic factors influencing hydroxyurea response in tanzanian sickle cell disease patients: a genomic medicine approachSiana Nkya, Collin Nzunda, Emmanuel Saukiwa, et al.
The Lancet. Psychiatry|April 1, 2017
Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trialIan M Anderson, Andrew Blamire, Tim Branton, et al.
BMC Psychiatry|October 23, 2015
Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study)Liam Trevithick, R Hamish McAllister-Williams, Andrew Blamire, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The Cochrane Database of Systematic Reviews|March 14, 2019
Computerised cognitive training for preventing dementia in people with mild cognitive impairmentNicola J Gates, Robin Wm Vernooij, Marcello Di Nisio, et al.
International Journal of Geriatric Psychiatry|March 18, 2011
The symptomatology of Alzheimer's disease: a cross-cultural studySalman Karim, Hassan M Minhas, Sharmi Bhattacharya, et al.
The Cochrane Database of Systematic Reviews|March 14, 2019
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlifeNicola J Gates, Anne Ws Rutjes, Marcello Di Nisio, et al.
The Cochrane Database of Systematic Reviews|March 14, 2019
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in late lifeNicola J Gates, Anne Ws Rutjes, Marcello Di Nisio, et al.
The Cochrane Database of Systematic Reviews|February 28, 2020
Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late lifeNicola J Gates, Anne Ws Rutjes, Marcello Di Nisio, et al.
BMJ Open|April 9, 2025
Prevalence of dementia and mild cognitive impairment among the older prisoner population in England and Wales: a cross-sectional studyKatrina Forsyth, Baber Malik, Roger Webb, et al.
BMC Medical Genomics|July 18, 2024
Towards genomic medicine: a tailored next-generation sequencing panel for hydroxyurea pharmacogenomics in TanzaniaSiana Nkya, Collin Nzunda, Emmanuel Saukiwa, et al.
The Pharmacogenomics Journal|April 23, 2025
Exploring pharmacogenetic factors influencing hydroxyurea response in tanzanian sickle cell disease patients: a genomic medicine approachSiana Nkya, Collin Nzunda, Emmanuel Saukiwa, et al.
The Lancet. Psychiatry|April 1, 2017
Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trialIan M Anderson, Andrew Blamire, Tim Branton, et al.
BMC Psychiatry|October 23, 2015
Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study)Liam Trevithick, R Hamish McAllister-Williams, Andrew Blamire, et al.
Pageof 3